Követés
Bertalan Németh
Bertalan Németh
Senior Health Economist, Syreon Research Institute // Past President of the Hungarian Health
E-mail megerősítve itt: syreon.eu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low-and middle-income countries
B Németh, A Molnár, S Bozóki, K Wijaya, A Inotai, JD Campbell, Z Kaló
Journal of comparative effectiveness research 8 (4), 195-204, 2019
1402019
Quality-adjusted life year difference in patients with predominant negative symptoms of schizophrenia treated with cariprazine and risperidone
B Németh, A Molnár, R Akehurst, M Horváth, K Kóczián, G Németh, ...
Journal of comparative effectiveness research 6 (8), 639-648, 2017
432017
A systematic review of the indirect costs of schizophrenia in Europe
A Fasseeh, B Németh, A Molnár, FU Fricke, M Horváth, K Kóczián, ...
European journal of public health 28 (6), 1043-1049, 2018
422018
Guidance toward the implementation of multicriteria decision analysis framework in developing countries
A Inotai, HT Nguyen, B Hidayat, T Nurgozhin, PHT Kiet, JD Campbell, ...
Expert review of pharmacoeconomics & outcomes research 18 (6), 585-592, 2018
392018
A systematic review of health economic models and utility estimation methods in schizophrenia
B Németh, A Fasseeh, A Molnár, I Bitter, M Horváth, K Kóczián, Á Götze, ...
Expert review of pharmacoeconomics & outcomes research 18 (3), 267-275, 2018
362018
Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals–an application on improving tender decision making in Indonesia
A Inotai, D Brixner, N Maniadakis, I Dwiprahasto, E Kristin, A Prabowo, ...
BMC health services research 18 (1), 1-12, 2018
302018
Cost‐effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD
M Trapero‐Bertran, C Muñoz, K Coyle, D Coyle, A Lester‐George, R Leidl, ...
Addiction 113, 65-75, 2018
272018
Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation
K Coyle, D Coyle, A Lester‐George, R West, B Nemeth, M Hiligsmann, ...
Addiction, 2017
252017
Drug Policy in Central Eastern Europe—Hungary
A Inotai, M Csanádi, A Harsányi, B Németh
Value in health regional issues 13, 16-22, 2017
192017
Overview on the current implementation of health technology assessment in the healthcare system in Hungary
B Németh, M Csanádi, Z Kaló
International journal of technology assessment in health care 33 (3), 333-338, 2017
192017
The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries
B Németh, W Goettsch, FB Kristensen, O Piniazhko, M Huić, T Tesař, ...
Expert Review of Pharmacoeconomics & Outcomes Research 20 (4), 321-330, 2020
182020
Health Technology Assessment Implementation in Ukraine: Current Status and Future Perspectives
M Csanádi, A Inotai, O Oleshchuk, O Lebega, B Alexandra, O Piniazhko, ...
International journal of technology assessment in health care 35 (5), 393-400, 2019
182019
Evidence requirements for reimbursement of pharmaceuticals across Europe
O Oyebode, Z Garrett, E George, A Cangini, LAA Muscolo, S Warren, ...
International journal of technology assessment in health care 31 (1-2), 59-67, 2015
162015
Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries
K Tachkov, A Zemplenyi, M Kamusheva, M Dimitrova, P Siirtola, J Pontén, ...
Frontiers in Public Health, 2170, 2022
132022
Cost‐effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD
MB Huber, M Präger, K Coyle, D Coyle, A Lester‐George, ...
Addiction 113, 52-64, 2018
132018
Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and …
I Jakab, B Nemeth, B Elezbawy, MA Karadayı, H Tozan, S Aydın, J Shen, ...
Frontiers in pharmacology 11, 1203, 2020
122020
Criteria and scoring functions used in multi-criteria decision analysis and value frameworks for the assessment of rare disease therapies: a systematic literature review
T Zelei, ND Mendola, B Elezbawy, B Németh, JD Campbell
PharmacoEconomics-open 5 (4), 605-612, 2021
112021
European cooperation in health technology assessment implementation: the perspective of Central and Eastern European countries
B Németh, Z Kaló
Journal of Comparative Effectiveness Research 9 (9), 599-602, 2020
112020
Cost‐effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD
B Németh, J Józwiak‐Hagymásy, G Kovács, A Kovács, T Demjén, ...
Addiction 113, 76-86, 2018
112018
Cost-utility analysis of cariprazine compared to risperidone among patients with negative symptoms of schizophrenia
B Németh, R Bendes, B Nagy, Á Götze, K Kóczián, M Horváth, I Deák, ...
Health Policy and Technology 8 (1), 84-91, 2019
102019
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20